about
Certolizumab pegol for the treatment of psoriasis.Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis.Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis.Biologics in inflammatory immune-mediated systemic diseases.Biologics in inflammatory and immunomediated arthritis.A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis.Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease.Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the LiteratureIsolated Aortitis Presenting with an Annoying Persistent Cough: A Case ReportA young man with persistent dyspepsia: the unexpected virtue of proton-pump inhibitors.Widespread painful nodules in a patient with rheumatoid arthritisChronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndromeMycophenolate mofetil-induced colitis in a patient with systemic sclerosisA painful diagnosisVideofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological featuresClinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinicAtypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemiaSubcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systemsThe neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factorsBiomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet NeedsClinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritisEnteropathic spondyloarthritis: Results from a large nationwide database analysisIs There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?
P50
Q38976796-EF3B5946-59D1-42C9-8C64-DA691A86E83DQ40425834-FFFF0C94-7F21-4A72-B3A2-B10BFB9059B3Q47132472-8954B01C-2C22-4A76-9A38-638A337DB1F7Q48543621-44088352-5C94-49DC-B65F-718091D218D5Q49575266-14C1DA0C-7153-4D28-B97E-B0BBF72C1461Q49575282-FCC48972-21D0-4F38-8197-D8A2F04DCD77Q49927821-B84FCB09-AA58-44F8-AAEC-61794C7903A9Q50118739-63FC4590-1B93-4578-888C-C648042DC9FFQ56893186-7806599B-64C5-40A5-ABD0-738863F3C6F8Q64048687-26810530-A3D2-4F24-8C67-13D7AC1EF27CQ64986395-C1770C3E-D336-4030-9EBA-DE21A0652C02Q88010206-E0C6814E-3C89-4091-B04F-3B97502C2AC4Q88074639-3E39A10F-2464-40AD-A65D-229F88E1F83BQ88732120-BC05B5B5-F5D0-4D9E-B768-21F744168125Q89365937-A03D9679-5C41-4DB4-8E1F-FF71EC1C23B8Q90522410-605D4E03-2360-4BDE-B08F-88DF2D15C7DCQ90593383-CBA7F5C6-C583-42B9-A0CE-E801AB2508A1Q90596827-5EAC2412-D7E9-4FA2-AC0D-FE9BBA8B0F10Q91307955-DDE502DC-34D0-4ED9-AECE-F79B639E82E6Q91581453-82068A4B-41AD-40DD-B6FC-AA904631ADE4Q91645594-0F282732-AAE9-4128-A1AD-A530AAA72C9AQ91705649-9BC1EF81-43AA-4648-87CC-9BAD0A6362F8Q91982627-1CF48F56-8656-4D3A-A96F-53EE3428E19BQ92354379-B4EB2B6B-2B77-4F81-A453-5F6FEFABE126
P50
description
researcher ORCID ID = 0000-0002-9867-2360
@en
name
Devis Benfaremo
@ast
Devis Benfaremo
@en
Devis Benfaremo
@es
Devis Benfaremo
@nl
type
label
Devis Benfaremo
@ast
Devis Benfaremo
@en
Devis Benfaremo
@es
Devis Benfaremo
@nl
prefLabel
Devis Benfaremo
@ast
Devis Benfaremo
@en
Devis Benfaremo
@es
Devis Benfaremo
@nl
P1153
57192238190
P31
P496
0000-0002-9867-2360